🌿 "Cannabinoids Show Promise in MS Management" Research from 8 studies suggests significant benefits for MS patients. Explore how cannabinoids can help. 📖 Study: https://t.co/penp3TiCWe 👉 More: https://t.co/2x1JtRcYm1 #MedicalCannabis #MultipleSclerosis
@Cosmetexpert @indy_yet Un bon essai clinique permettrait de lever les doutes. https://t.co/M6K2nZyqYu
@avocatine Non, vous affirmez. Lisez un peu. https://t.co/8gGZ7Hht2t https://t.co/X389AJt365 Qu'il est agréable de se faire traiter de con et de haineux par une personne aussi pertinente que vous !
Spasticity and chronic neuropathic pain are common and serious symptoms in people with #multiplesclerosis (MS). These symptoms increase with disease progression and lead to worsening disability, impaired activities of daily living and quality of life.
RT @CochraneCAM: Can #cannabis and cannabinoid medicines help with symptoms of Multiple Sclerosis (#MS) in adults? Get the current #healthe…
Can #cannabis and cannabinoid medicines help with symptoms of Multiple Sclerosis (#MS) in adults? Get the current #healthevidence picture in this review from the @CochraneLibrary: https://t.co/g68j2PWzgS #WorldMSDay #multiplesclerosis #cbd #painmanagement
RT @CochraneCAM: Can #cannabis and cannabinoid medicines help with symptoms of Multiple Sclerosis (#MS) in adults? Get the current #healthe…
RT @CochraneCAM: Can #cannabis and cannabinoid medicines help with symptoms of Multiple Sclerosis (#MS) in adults? Get the current #healthe…
Can #cannabis and cannabinoid medicines help with symptoms of Multiple Sclerosis (#MS) in adults? Get the current #healthevidence picture in this review from @CochraneLibrary: https://t.co/g68j2PWzgS #multiplesclerosis #cbd #420day #painmanagement https:/
RT @dagfinnhessenp: @CiViX @CSchjelderup @MinaGerhardsen Det er feil at evidensen for effekt av Sativex er veldig svak, Cochrane-gruppen be…
RT @dagfinnhessenp: @CiViX @CSchjelderup @MinaGerhardsen Det er feil at evidensen for effekt av Sativex er veldig svak, Cochrane-gruppen be…
@CiViX @CSchjelderup @MinaGerhardsen Det er feil at evidensen for effekt av Sativex er veldig svak, Cochrane-gruppen betegner evidensen som moderat: https://t.co/WUM34OhfEZ https://t.co/BvfCfUIgxG
多発性硬化症患者の対症療法としての医療用大麻およびカンナビノイド https://t.co/sEy1quFcYZ
Outro, um pouco mais: https://t.co/zlHgUKOlIt
21) A @cochranelibrary report found that #cannabinoids “probably increase the number of people who report an important reduction of perceived severity of #spasticity compared with placebo.” See https://t.co/iKpVoVqBPY
18) There are several routes of administration for #Cannabanoids including inhalation, oral, oromucosal, sublingual, transdermal, eye drops, topical, and rectal. Clinically, inhalation, oromucosal and oral are most common. See https://t.co/iKpVoV8sBQ
RT @Cochrane_DE: Ein neu übersetzter Cochrane Review auf Cochrane Kompakt ist moderat zuversichtlich, dass Cannabinoide besser wirken als k…
Ein neu übersetzter Cochrane Review auf Cochrane Kompakt ist moderat zuversichtlich, dass Cannabinoide besser wirken als keine Cannabinoide, um den Schweregrad der Spastizität und das Wohlbefinden bei Erwachsenen mit Multipler Sklerose zu verbessern. https
A current summary of the evidence for cannabis in symptom management of #MS, in podcast form!
#Cannabis and #cannabinoids for people with multiple sclerosis #MS 🎧 Listen to the podcast the #CochranePodcast 🌟 Also on @Spotify & @ApplePodcasts 📃 Based on systematic review: https://t.co/HCt6Cx3suo https://t.co/mmelT7Xuwd
RT @CochraneLibrary: #Cannabis and #cannabinoids for people with multiple sclerosis #MS 🎧 Listen to the podcast the #CochranePodcast https…
#Cannabis and #cannabinoids for people with multiple sclerosis #MS 🎧 Listen to the podcast the #CochranePodcast https://t.co/u2gR3q8DHs 🌟 Also on @Spotify & @ApplePodcasts 📃 Based on systematic review: https://t.co/HCt6Cx3suo https://t.co/E2F78OnUz2
Cannabis et cannabinoïdes pour les personnes atteintes de sclérose en plaques https://t.co/DumkXnR8yM
@retratodememori @adonadoteto @josenalencar O efeito é muito pequeno, em uma forma bastante rara de epilepsia. Eu juntei tudo que tem na Cochrane sobre o assunto. Não é muito animador. https://t.co/hYIfLorKlH
@naoempurra @rachcoelho @fatsanchez @leandrotessler @josenalencar @lcos3060 https://t.co/EmkXpxv2t0 Olhe essa revisão da Cochrane, para pessoas com esclerose múltipla pode ser útil. https://t.co/fQjrWsmi9r Já para pessoas com fibromialgia não se justific
RT @CochraneCAM: Can #cannabis and #cannabinoid medicines help with symptoms of Multiple Sclerosis (#MS) in adults? Get #healthevidence you…
@lftofoli @josegallucci @vitorborin_ @chloepinheiro Por isso. https://t.co/dQmbvmW3a9 https://t.co/hinQZ4hAH5 https://t.co/mSKi3kRKFX https://t.co/2nJXounoVK https://t.co/8cyXvrCbQQ A evidência frágil, que você chama de moderada está em: https://t.co/TAleb
Can #cannabis and #cannabinoid medicines help with symptoms of Multiple Sclerosis (#MS) in adults? Get #healthevidence you can use in this review from the Cochrane Multiple Sclerosis Group: https://t.co/fS04ftFTqr #cns #painmanagement #multiplesclerosis h
RT @CochraneRehab: 📣A new #blogshot is available! "Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis.…
📣A new #blogshot is available! "Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis." 👉Full review here: https://t.co/gMxNdtjBXH 👉Take a look at the Tumblr archive: https://t.co/SvpzKN2sO4 #CochraneRehab #rehabilitatio
Cannabis et cannabinoïdes pour les personnes atteintes de sclérose en plaques https://t.co/DumkXnR8yM
RT @CochraneIberoam: #Cannabis y cannabinoides para personas con esclerosis múltiple, nueva revisión con 25 ensayos. Conoce los resultados…
RT @CochraneJapan: 多発性硬化症患者の対症療法としての医療用大麻およびカンナビノイド https://t.co/VfOH5bgQbI
RT @CochraneJapan: 多発性硬化症患者の対症療法としての医療用大麻およびカンナビノイド https://t.co/VfOH5bgQbI
多発性硬化症患者の対症療法としての医療用大麻およびカンナビノイド https://t.co/VfOH5bgQbI
RT @daperezm: Revisión Cochrane sobre efecto de cannabinoides en la Esclerosis Múltiple: 👉 No hay evidencia de alta calidad 👉 Parecen mejor…
RT @daperezm: Revisión Cochrane sobre efecto de cannabinoides en la Esclerosis Múltiple: 👉 No hay evidencia de alta calidad 👉 Parecen mejor…
RT @daperezm: Revisión Cochrane sobre efecto de cannabinoides en la Esclerosis Múltiple: 👉 No hay evidencia de alta calidad 👉 Parecen mejor…
RT @daperezm: Revisión Cochrane sobre efecto de cannabinoides en la Esclerosis Múltiple: 👉 No hay evidencia de alta calidad 👉 Parecen mejor…
RT @daperezm: Revisión Cochrane sobre efecto de cannabinoides en la Esclerosis Múltiple: 👉 No hay evidencia de alta calidad 👉 Parecen mejor…
RT @daperezm: Revisión Cochrane sobre efecto de cannabinoides en la Esclerosis Múltiple: 👉 No hay evidencia de alta calidad 👉 Parecen mejor…
RT @daperezm: Revisión Cochrane sobre efecto de cannabinoides en la Esclerosis Múltiple: 👉 No hay evidencia de alta calidad 👉 Parecen mejor…
RT @daperezm: Revisión Cochrane sobre efecto de cannabinoides en la Esclerosis Múltiple: 👉 No hay evidencia de alta calidad 👉 Parecen mejor…
RT @daperezm: Revisión Cochrane sobre efecto de cannabinoides en la Esclerosis Múltiple: 👉 No hay evidencia de alta calidad 👉 Parecen mejor…
Revisión Cochrane sobre efecto de cannabinoides en la Esclerosis Múltiple: 👉 No hay evidencia de alta calidad 👉 Parecen mejorar la gravedad de Espasticidad 👉 El efecto sobre dolor neuropático es dudoso 👉 La evidencia sobre efectos adversos es limitada http
RT @CochraneIberoam: #Cannabis y cannabinoides para personas con esclerosis múltiple, nueva revisión con 25 ensayos. Conoce los resultados…
RT @CochraneLibrary: 💚A UK survey found that 1 in 5 people with #MS reported they used #Cannabis to manage symptoms. 🤔 Does it work? Are t…
RT @CochraneLibrary: 💚A UK survey found that 1 in 5 people with #MS reported they used #Cannabis to manage symptoms. 🤔 Does it work? Are t…
RT @CochraneIberoam: #Cannabis y cannabinoides para personas con esclerosis múltiple, nueva revisión con 25 ensayos. Conoce los resultados…
New Cochrane review: "Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis" #MedicalCannabis #MedicalMarijuana #SystematicReviews https://t.co/rmZKL90u9l
RT @CochraneIberoam: #Cannabis y cannabinoides para personas con esclerosis múltiple, nueva revisión con 25 ensayos. Conoce los resultados…
RT @CochraneIberoam: #Cannabis y cannabinoides para personas con esclerosis múltiple, nueva revisión con 25 ensayos. Conoce los resultados…
An updated (new) review of cannabinoids (synthetic drug & herbal) in treatment of Multiple Sclerosis. Nabiximols seems to have strongest effect, with positives for cannabinoids to0 (quality of life). Read the paper - https://t.co/coltuCb2cx #THC #MS #c
Cannabis y cannabinoides para el tratamiento sintomático de las personas con esclerosis múltiple (5.05.2022) https://t.co/JXheblQXYR 🌿En comparación con el placebo, el nabiximols probablemente reduce la gravedad de la espasticidad a corto plazo en persona
#Cannabis y cannabinoides para personas con esclerosis múltiple, nueva revisión con 25 ensayos. Conoce los resultados clave aquí 👇🏽 (1/4) https://t.co/HAihBbujhU #EM https://t.co/EEFx42NcWb
Cannabinoides para el tratamiento sintomático de personas con esclerosis múltiple: Respecto del placebo, el nabiximols probablemente reduce la gravedad de la espasticidad a corto plazo. No está claro el efecto sobre el dolor neurológico ni calidad de vida.
"Compared with placebo, nabiximols probably reduces the severity of spasticity in the short‐term in people with #MultipleSclerosis. (..) The overall certainty of evidence is limited by short‐term duration of the included studies." @cochranecollab https://
RT @CochraneLibrary: 💚A UK survey found that 1 in 5 people with #MS reported they used #Cannabis to manage symptoms. 🤔 Does it work? Are t…
RT @CochraneLibrary: 💚A UK survey found that 1 in 5 people with #MS reported they used #Cannabis to manage symptoms. 🤔 Does it work? Are t…
RT @CochraneLibrary: 💚A UK survey found that 1 in 5 people with #MS reported they used #Cannabis to manage symptoms. 🤔 Does it work? Are t…
💚A UK survey found that 1 in 5 people with #MS reported they used #Cannabis to manage symptoms. 🤔 Does it work? Are there harms? 📚 Cochrane systematic review looks at 25 RCTs ➡️ https://t.co/HCt6Cx3suo #MedicalMarijuana #MultipleSclerosis https://t.co/Qn
RT @theradelics: Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis https://t.co/PO8QRwNxqM https://t.c…
Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis https://t.co/PO8QRwNxqM https://t.co/DfVK2tlN5b
まぁMSについてはCBDは効果無いよねって感じですよね。 https://t.co/qxEq95biXV
RT @dwan_kerry: Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis @cochranecollab https://t.co/rQTDoc…
RT @dwan_kerry: Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis @cochranecollab https://t.co/rQTDoc…
Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis @cochranecollab https://t.co/rQTDocHE1T https://t.co/aF8QYlYkII
#CochraneDaily Published this week, @CochraneCollab review of #cannabis and #cannabinoids for symptomatic treatment for people with #MultipleSclerosis finds that nabiximols probably reduce severity of spasticity in the short‐term in people with MS https:/
RT @CochraneLibrary: 💚A UK survey found that 1 in 5 people with #MS reported they used #Cannabis to manage symptoms. 🤔 Does it work? Are t…
RT @CochraneLibrary: 💚A UK survey found that 1 in 5 people with #MS reported they used #Cannabis to manage symptoms. 🤔 Does it work? Are t…
A recent #CochraneReview assess benefit and harms of cannabinoids, including synthetic, or herbal and plant-derived #cannabinoids, for reducing symptoms for adults with #MS. https://t.co/pHAsM7m5QK https://t.co/iqReKyd9zm
New article: Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis https://t.co/psGor1BOby #MS #multiplesclerosis #neurology https://t.co/MLJ2rhJ5Un
RT @CochraneLibrary: 💚A UK survey found that 1 in 5 people with #MS reported they used #Cannabis to manage symptoms. 🤔 Does it work? Are t…
RT @CochraneLibrary: 💚A UK survey found that 1 in 5 people with #MS reported they used #Cannabis to manage symptoms. 🤔 Does it work? Are t…
RT @CochraneLibrary: 💚A UK survey found that 1 in 5 people with #MS reported they used #Cannabis to manage symptoms. 🤔 Does it work? Are t…
RT @CochraneLibrary: 💚A UK survey found that 1 in 5 people with #MS reported they used #Cannabis to manage symptoms. 🤔 Does it work? Are t…
RT @CochraneLibrary: 💚A UK survey found that 1 in 5 people with #MS reported they used #Cannabis to manage symptoms. 🤔 Does it work? Are t…
💚A UK survey found that 1 in 5 people with #MS reported they used #Cannabis to manage symptoms. 🤔 Does it work? Are there harms? 📚 Cochrane systematic review looks at 25 RCTs ➡️ https://t.co/HCt6Cx3suo #MedicalMarijuana #MultipleSclerosis https://t.co/wj